First Time Loading...
S

Shanghai Kai Kai Industry Co Ltd
SSE:600272

Watchlist Manager
Shanghai Kai Kai Industry Co Ltd
SSE:600272
Watchlist
Price: 10.3 CNY -0.68% Market Closed
Updated: May 21, 2024

Net Margin
Shanghai Kai Kai Industry Co Ltd

5.5%
Current
4%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.5%
=
Net Income
52.8m
/
Revenue
959.8m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
CN
Shanghai Kai Kai Industry Co Ltd
SSE:600272
1.7B CNY
6%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-79%
US
Eli Lilly and Co
NYSE:LLY
744.3B USD
17%
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK
37%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
364.1B USD
45%
US
Merck & Co Inc
NYSE:MRK
331.8B USD
4%
UK
AstraZeneca PLC
LSE:AZN
187.5B GBP
13%
CH
Roche Holding AG
SIX:ROG
189B CHF
20%
CH
Novartis AG
SIX:NOVN
182.7B CHF
30%
US
Pfizer Inc
NYSE:PFE
161.7B USD
-1%
S
Shanghai Kai Kai Industry Co Ltd
SSE:600272
Country CN
Market Cap 1.7B CNY
Net Margin
6%
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Eli Lilly and Co
NYSE:LLY
Country US
Market Cap 744.3B USD
Net Margin
17%
Novo Nordisk A/S
CSE:NOVO B
Country DK
Market Cap 4T DKK
Net Margin
37%
Dechra Pharmaceuticals PLC
LSE:DPH
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Johnson & Johnson
NYSE:JNJ
Country US
Market Cap 364.1B USD
Net Margin
45%
Merck & Co Inc
NYSE:MRK
Country US
Market Cap 331.8B USD
Net Margin
4%
AstraZeneca PLC
LSE:AZN
Country UK
Market Cap 187.5B GBP
Net Margin
13%
Roche Holding AG
SIX:ROG
Country CH
Market Cap 189B CHF
Net Margin
20%
Novartis AG
SIX:NOVN
Country CH
Market Cap 182.7B CHF
Net Margin
30%
Pfizer Inc
NYSE:PFE
Country US
Market Cap 161.7B USD
Net Margin
-1%

Profitability Report

View the profitability report to see the full profitability analysis for Shanghai Kai Kai Industry Co Ltd.

Full Profitability Report

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.5%
=
Net Income
52.8m
/
Revenue
959.8m
What is the Net Margin of Shanghai Kai Kai Industry Co Ltd?

Based on Shanghai Kai Kai Industry Co Ltd's most recent financial statements, the company has Net Margin of 5.5%.

ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.